Lupin launches Sildenafil for Oral Suspension in United States

29 Sep 2022 Evaluate

Lupin has launched Sildenafil for Oral Suspension, 10 mg/mL, having received an approval from the United States Food and Drug Administration (FDA). Sildenafil for Oral Suspension, 10 mg/mL, is a generic equivalent of Revatio for Oral Suspension, 10 mg/mL of Viatris Specialty LLC. Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of $ 64 million in the U.S. (IQVIA MAT July 2022).

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2121.65 -25.95 (-1.21%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×